רקטוצורין משחה

Country: Israel

Language: Hebrew

Source: Ministry of Health

Buy It Now

Active ingredient:

BENZOCAINE; BISMUTH OXYCHLORIDE; MENTHOL; THYMOL BIIODIDE; ZINC OXIDE

Available from:

TEVA ISRAEL LTD

ATC code:

C05AX02

Pharmaceutical form:

משחה

Composition:

ZINC OXIDE 10 %W/W; BENZOCAINE 4 %W/W; MENTHOL 0.25 %W/W; BISMUTH OXYCHLORIDE 8 %W/W; THYMOL BIIODIDE 2 %W/W

Administration route:

אנאלי חיצוני

Prescription type:

אין צורך במרשם

Manufactured by:

TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL

Therapeutic group:

BISMUTH PREPARATIONS, COMBINATIONS

Therapeutic area:

BISMUTH PREPARATIONS, COMBINATIONS

Therapeutic indications:

Symptomatic relief of pain and discomfort in irritated anorectal tissues in: hemorrhoids, proctitis, papillitis, cryptitis, fissures and following anorectal surgery.

Authorization date:

2021-06-30

Patient Information leaflet

                                Rectozorin Oint and Supp, PIL Minor Updates SZ 08.2023
ʬ ʯʥʬʲ
ʭʩʸʩʹʫʺ) ʭʩʧʷʥʸʤ ʺʥʰʷʺ ʩʴʬ ʯʫʸʶ
ʥ"ʮʹʺʤ (
-
1986
ʠʴʥʸ ʭʹʸʮ ʠʬʬ ʺʷʥʥʹʮ ʤʴʥʸʺʤ
ʯʩʸʥʶʥʨʷʸ
®
ʤʧʹʮ
ʡʫʸʤ
ʵʡʠ
ʣʩʱʷʥʠ
10.0%
Zinc oxide
ʣʩʸʥʬʫʩʱʷʥʠ ʨʥʮʱʩʡ
8.0%
Bismuth oxychloride
ʯʩʠʷʥʦʰʡ
4.0%
Benzocaine
ʺ
ʩʡ ʬʥʮʩ
-
ʣʩʣʥʩ
2.0%
Thymol biiodide
ʬʥʨʰʮ
0.25%
Menthol
ʯʩʸʥʶʥʨʷʸ
®
ʺʥʬʩʺʴ
ʡʫʸʤ
:ʤʬʩʫʮ ʤʬʩʺʴ ʬʫ
ʺ
ʩʡ ʬʥʮʩ
-
ʣʩʣʥʩ
150
ʢ"ʮ
Thymol biiodide
ʨʬʠʢʡʱ ʨʥʮʱʩʡ
100
ʢ"ʮ
Bismuth subgallate
ʵʡʠ
ʣʩʱʷʥʠ
100
ʢ"ʮ
Zinc oxide
ʯʩʠʷʥʦʰʡ
100
ʢ"ʮ
Benzocaine
ʺʩʰʠʨ ʤʶʮʥʧ
20
ʢ"ʮ
Tannic acid
ʬʥʨʰʮ
5
ʢ"ʮ
Menthol
ʲʣʩʮʬ
ʬʲ
ʭʩʡʩʫʸʮ
ʩʺʬʡ
ʭʩʬʩʲʴ
ʭʩʩʰʢʸʬʠʥ
ʤʠʸ
ʳʩʲʱ
2
-
"
ʡʥʹʧ ʲʣʩʮ
ʬʲ
ʷʬʧ
ʭʩʡʩʫʸʮʤʮ
ʬʹ
ʤʴʥʸʺʤ
"
ʳʩʲʱʥ
6
"
ʲʣʩʮ
ʳʱʥʰ
"
.
ʤʴʥʸʺʡ ʹʮʺʹʺ ʭʸʨʡ ʥʴʥʱ ʣʲ ʯʥʬʲʤ ʺʠ
ʯʥʩʲʡ ʠʸʷ
.
ʩʶʮʺ ʲʣʩʮ ʬʩʫʮ ʤʦ ʯʥʬʲ
.ʤʴʥʸʺʤ ʬʲ ʩʺ
.ʧʷʥʸʤ ʬʠ ʥʠ ʠʴʥʸʤ ʬʠ ʤʰʴ ,ʺʥʴʱʥʰ ʺʥʬʠʹ
ʪʬ ʹʩ ʭʠ
ʳʩʲʱʡ ʺʥʠʸʥʤʤ ʩʴ ʬʲ ʤʴʥʸʺʡ ʹʮʺʹʤʬ ʪʩʬʲ
3
ʲʣʩʮʬ ʷʥʷʦ ʤʺʠ ʭʠ ʧʷʥʸʡ ʵʲʥʥʩʤ .ʤʦ
ʯʥʬʲʡ
ʠʴʥʸʬ ʺʥʰʴʬ ʪʩʬʲ .ʳʱʥʰ
ʭʠ
ʭʩʸʩʮʧʮ (ʭʩʮʥʨʴʮʩʱ) ʤʬʧʮʤ ʩʰʩʮʱʺ
ʭʩʸʴʺʹʮ ʭʰʩʠ ʥʠ
.
ʺʧʺʮ ʭʩʬʴʥʨʮʬ ʺʣʲʥʩʮ ʤʰʩʠ ʤʴʥʸʺʤ
ʬʩʢʬ
18
.ʭʩʰʹ
1
.
?ʤʴʥʸʺʤ ʺʣʲʥʩʮ ʤʮʬ
ʤʬʷʤ
ʩʡʠʫʡ
.ʭʩʸʥʧʨ
ʺʩʨʩʥʴʸʺ ʤʶʥʡʷ
ʹʥʮʩʹʬ ʭʩʸʥʧʨʡ ʬʥʴʩʨʬ ʭʩʸʩʹʫʺ
ʺʲʡʨʤ ʩʴʡ
)
ʹʥʮʩʹ
(ʩʬʠʨʷʸ
.
2
.
ʤʴʥʸʺʡ ʹʥʮʩʹʤ ʩʰʴʬ
ʤʴʥʸʺʡ ʹʮʺʹʤʬ ʯʩʠ
ʭʠ
:

ʤʴʥʸʺʤ ʤʬʩʫʮ ʸʹʠ ʭʩʴʱʥʰʤ ʭʩʡʩʫʸʮʤʮ
ʣʧʠ ʬʫʬ ʥʠ ʭʩʬʩʲʴʤ ʭʩʸʮʥʧʬ (ʩʢʸʬʠ) ʹʩʢʸ
ʤʺʠ
,
ʠʸ
ʳʩʲʱ ʤ
6
-
."ʳʱʥʰ ʲʣʩʮ"

                                
                                Read the complete document
                                
                            

Documents in other languages

Patient Information leaflet Patient Information leaflet English 16-03-2023
Public Assessment Report Public Assessment Report English 29-11-2022
Patient Information leaflet Patient Information leaflet Arabic 16-03-2023